Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diffuse Intrinsic Pontine Glioma × Vinorelbine × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Brain Neoplasms 4 Neuroblastoma 2 Uterine Cervical Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma, Extra-Adrenal 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Connective and Soft Tissue 1 Neoplasm Metastasis 1 Meningeal Carcinomatosis 1 Medulloblastoma 1 Familial ependymoma 1 Endometrial Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Medullary 1 Carcinoma, Islet Cell 1 Breast Neoplasms, Male 1 Astrocytoma 1

Interventions

Temozolomide 15 Radiotherapy 10 Bevacizumab 6 Irinotecan 5 Everolimus 5 Cyclophosphamide 5 ribociclib 4 Radiation 4 TIC10 compound 3 Re-Irradiation 3 Panobinostat 3 Etoposide 3 Dasatinib 3 pembrolizumab 2 nimotuzumab 2 abemaciclib 2 Vorinostat 2 Valproic Acid 2 Topotecan 2 Specimen Handling 2 Nivolumab 2 Mebendazole 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 GDC-0084 2 Erlotinib Hydrochloride 2 Diphtheria-Tetanus Vaccine 2 Cilengitide 2 Cetuximab 2 1-methyltryptophan 2 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03620032 2023-12-06

DIPG

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡